EOLS
Evolus Inc
Price:  
11.51 
USD
Volume:  
394,506.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EOLS EV/EBITDA

-155.6%
Upside

As of 2024-12-15, the EV/EBITDA ratio of Evolus Inc (EOLS) is -30.36. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. EOLS's latest enterprise value is 764.99 mil USD. EOLS's TTM EBITDA according to its financial statements is -25.20 mil USD. Dividing these 2 quantities gives us the above EOLS EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.8x - 10.8x 10.1x
Forward P/E multiples 16.6x - 20.3x 19.2x
Fair Price (7.19) - (4.89) (6.40)
Upside -162.5% - -142.4% -155.6%
11.51 USD
Stock Price
(6.40) USD
Fair Price

EOLS EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-12-10 -31.69
2024-12-09 -32.04
2024-12-06 -33.25
2024-12-05 -33.32
2024-12-04 -34.00
2024-12-03 -34.35
2024-12-02 -35.38
2024-11-29 -35.84
2024-11-27 -36.11
2024-11-26 -33.68
2024-11-25 -33.27
2024-11-22 -33.10
2024-11-21 -34.20
2024-11-20 -33.17
2024-11-19 -32.57
2024-11-18 -31.57
2024-11-15 -31.87
2024-11-14 -31.29
2024-11-13 -32.22
2024-11-12 -32.70
2024-11-11 -34.40
2024-11-08 -35.81
2024-11-07 -37.34
2024-11-06 -43.68
2024-11-05 -42.87
2024-11-04 -42.70
2024-11-01 -43.53
2024-10-31 -42.45
2024-10-30 -43.53
2024-10-29 -43.38
2024-10-28 -42.32
2024-10-25 -42.80
2024-10-24 -41.11
2024-10-23 -40.71
2024-10-22 -41.74
2024-10-21 -42.25
2024-10-18 -43.20
2024-10-17 -43.23
2024-10-16 -45.29
2024-10-15 -43.40
2024-10-14 -44.76
2024-10-11 -43.90
2024-10-10 -43.02
2024-10-09 -43.58
2024-10-08 -42.90
2024-10-07 -42.87
2024-10-04 -42.50
2024-10-03 -44.28
2024-10-02 -44.51
2024-10-01 -44.21